March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
ABCA4 Genotypic Diversity And Phenotypic Correlates In Stargardt Disease
Author Affiliations & Notes
  • Virginia M. Utz
    Cole Eye Institute, The Cleveland Clinic, Cleveland, Ohio
  • Aimee V. Chappelow
    Cole Eye Institute, The Cleveland Clinic, Cleveland, Ohio
  • Susan Crowe
    Cole Eye Institute, The Cleveland Clinic, Cleveland, Ohio
  • Gayle J. Pauer
    Cole Eye Institute, The Cleveland Clinic, Cleveland, Ohio
  • Stephanie A. Hagstrom
    Cole Eye Institute, The Cleveland Clinic, Cleveland, Ohio
  • Elias I. Traboulsi
    Cole Eye Institute, The Cleveland Clinic, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Virginia M. Utz, None; Aimee V. Chappelow, None; Susan Crowe, None; Gayle J. Pauer, None; Stephanie A. Hagstrom, None; Elias I. Traboulsi, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 4557. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Virginia M. Utz, Aimee V. Chappelow, Susan Crowe, Gayle J. Pauer, Stephanie A. Hagstrom, Elias I. Traboulsi; ABCA4 Genotypic Diversity And Phenotypic Correlates In Stargardt Disease. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4557.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To characterize genotypic diversity and to correlate ABCA4 genotype with clinical phenotype in a population of patients with Stargardt disease.

 
Methods:
 

We reviewed 244 patients with a clinical diagnosis of Stargardt Disease examined between 1998 and June 2011 at the Cole Eye Institute. The following data was extracted from the medical record: age, visual acuity, retinal abnormalities on initial and final visit, fluorescein angiographic changes, ERG amplitude/implicit time, optical coherence tomography and fundus autofluorescence whenever these studies were performed.

 
Results:
 

Sixty-seven distinct mutations were identified in 78 patients of 75 families, of which 22 were common to multiple patients. Five different mutations accounted for 50% of the identified disease alleles. In 35 of 78 patients (45%), only one mutant ABCA4 allele was detected, whereas in 13 patients (17 %) three disease-causing mutations were identified. The most common nucleotide change (c.5882G>A), a missense mutation resulting in a G1961E amino acid exchange, occurred in 11 alleles of 10 patients, and was associated with visual acuity better than 20/200 for all patients, ages 15 to 72 years. As reported previously, the presence of the c.5461-10T>C substitution, which is in linkage disequilibrium with a disease-causing mutation, was associated with early-onset disease, vision less than 20/200 and nystagmus by the second decade, as well as distinctive macular pigmentary clumping. Ten out of 11 unrelated African-American patients with known genotype shared 1 of 3 common mutations [c.6320G>A (R2107H), c.3602T>G (L1201R), c.3899G>A (R1300Q)] that in the present population were exclusive to the African-American subset.

 
Conclusions:
 

Stargardt disease is less diverse phenotypically among patients with identical mutations than among Stargardt patients as a whole. ABCA4 mutation analysis may assist in estimating visual prognosis on an individual basis.

 
Keywords: retinal degenerations: hereditary • genetics • gene screening 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×